Titlebook: Stem Cells and Cancer; Sadhan Majumder Book 2009 Springer-Verlag New York 2009 cancer.cancer research.cancer therapy.molecular mechanisms.

Boycott

insipid

Lineage Relationships Connecting Germinal Regions to Brain Tumors,entiated glia was widely assumed to be the only mechanism for gliomagenesis. Astrocytes and oligodendrocytes, once thought to be the sole dividing cells in the postnatal brain, were assumed to represent the cellular compartment most susceptible to transformation. More recently, however, this hypothe

Mangle

Book 2009 dismal. Some stumbling blocks to developing effective therapy include the heterogeneity of cancer tissues, the lack of knowledge about the critical molecular mechanisms in cancer tissues (which are typically aberrant compared with mechanisms in normal tissue), and the lack of good mechanism-based t

债务

MicroRNAs in Stem Cells and Cancer Stem Cells, miRNAs in cancer or tumor-initiating stem cells. We also comment on budding but promising therapeutic application of miRNAs in pathological scenario. Understanding this layer of regulation by miRNA will uncover many interesting avenues in future in learning the biology of life.

Crohns-disease

Gudgeon

Prostate Cancer Stem Cells,n what is known about these pathways in prostate cancer stem cells and how these pathways, and others, may be targeted to inhibit or kill the tumor-initiating cancer stem cells. In conclusion, we provide a short discussion on the future directions for study of prostate cancer stem cells.

nonchalance

Molecular Regulation of the State of Embryonic Stem Cells,ty of human ESCs and the capacity to reprogram somatic cells to a pluripotent state, we hope that a comprehensive description of the control of pluripotency in ESCs will contribute to the use of these cells in regenerative medicine.

说笑

Stem Cells in Leukemia and Other Hematological Malignancies,e to eradicate these very primitive cancer cells is a common cause of leukemia relapse. Therefore, improved understanding of the biology of LSCs and the differences between normal hematopoietic and leukemic stem cells is likely to lead to the development of novel therapeutic strategies and improvements in leukemia therapy and patient survival.

舰旗

就职